Scholarly Index
Eric Jonasch
The University of Texas MD Anderson Cancer Center; 22,413 total citations; 457 total publications; best world rank #55
The University of Texas MD Anderson Cancer Center
22,413Total citations
457Total publications
67H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Renal cell carcinoma treatment | Lifetime | 108 | US 71 | 99.32 |
| Renal and related cancers | Lifetime | 185 | US 108 | 98.96 |
| Cancer Genomics and Diagnostics | Lifetime | 472 | US 271 | 99.11 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 488 | US 232 | 98.64 |
| Ferroptosis and cancer prognosis | Lifetime | 324 | US 93 | 96.36 |
| Economic and Financial Impacts of Cancer | Lifetime | 226 | US 152 | 97.30 |
| Cancer Diagnosis and Treatment | Lifetime | 821 | US 373 | 96.33 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 55 | US 14 | 97.81 |
| Renal cell carcinoma treatment | 2021-2025 | 78 | US 31 | 98.61 |
| Renal and related cancers | 2021-2025 | 114 | US 55 | 96.34 |
| Cancer Research and Treatments | 2021-2025 | 281 | US 76 | 89.10 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 459 | US 165 | 77.58 |
| Cancer Diagnosis and Treatment | 2021-2025 | 969 | US 236 | 73.73 |
| Cancer-related Molecular Pathways | 2021-2025 | 821 | US 257 | 73.98 |